Sanofi bets big on mRNA future with Translate Bio acquisition offer

Sanofi bets big on mRNA future with Translate Bio acquisition offer

By Anna Domanska - Aug 03, 2021

Sanofi’s CEO Paul Hudson is dead serious about mRNA technology and capabilities with a $3.2 billion acquisition offer to Translate Bio.

Read More
Moderna Vaccine Shows 94.5% Efficacy in Early Analysis

Moderna Vaccine Shows 94.5% Efficacy in Early Analysis

By Anna Domanska - Nov 17, 2020

Get the latest updates and insights on COVID 19 vaccine here at the nation’s fastest-growing business magazine, Industry Leaders.

Read More